Royal Australian Navy - 👉 Bachelor of Electronic and Communications Engineering
Releaf, Business Of Cannabis, CPD, Cannabis Now Magazine, High Times, Cookies Seeds, Fast Buds, MSNL, Paradise Seeds, Premium Cultivars
Sam North is a content writer at Releaf, specialising in medical cannabis, digital health, and patient education within a UK regulatory framework. After a decade immersed in the cultivation side of the cannabis industry, Sam moved into digital in 2020. He worked across the recreational space with seed companies, CBD brands, and cannabis publications, before transitioning into the medical cannabis sector in early 2023 and joining Releaf in April of that year. Today, his work spans both content and SEO, with a focus on how the two support patient understanding and long-term organic growth. He writes and shapes educational content, research breakdowns, and patient-facing web copy, ensuring it is clear, clinically accurate, and aligned with UK compliance requirements. At Releaf, Sam’s focus is on making medical cannabis more understandable and accessible to patients, while maintaining a high standard of accuracy, compliance, and trust.
THC edibles and THC gummies are among the most popular and potentially therapeutically effective medical cannabis products available to UK medical cannabis patients, but they work a little differently to other formats. Taken by mouth, they pass through the digestive system, so the effects build gradually and tend to last longer than inhaled or sublingually administered cannabis product.
At Releaf, we prescribe two main formulations of cannabis-based medicines to our patients - medical cannabis flower and medical cannabis oil. Most people have a fair understanding of medical cannabis flower, but medical cannabis oil is still somewhat of an enigma to many.
While cannabis-based treatment options have been shown to offer patients a very favourable safety profile with a wide range of therapeutic benefits - like almost all medical options, there are side effects to consider.
Here at Releaf, medical cannabis oil is the second most commonly prescribed cannabis-based medication, right after medical cannabis flower - so to continue our 'New Patient' blog series, we are focusing on all things medical cannabis oil.
On the 12th of November, at 3 PM, Releaf is teaming up with MS-UK (the UK's leading multiple sclerosis charity) to bring patients, caregivers, and healthcare professionals a free webinar discussing the increasingly significant role of medicinal cannabis in treating symptoms associated with multiple sclerosis.
Medical cannabis flower is the most commonly prescribed cannabis-based medication here in the UK. But unlike most treatment options, both traditional and alternative, it is not delivered to patients in a fully 'ready-to-administer' form.
When we discuss the 'strength' (or potency) of a given medical cannabis cultivar, it is easy to fall into the trap of simply looking at the THC levels. This is only one part of the picture - but a crucial one, nonetheless.
Medical cannabis flower is the most prescribed CBPM in the UK, and it is intended to be administered through a dry herb vaporiser.
Medical cannabis has been a legal treatment option in the UK for just shy of six years now. However, it’s only within the past twelve months that the UK media has started to embrace the therapeutic potential of this remarkable plant, and its derivatives. This has recently led to a marked shift in public opinion and understanding of cannabis-based treatments.
Today, we continue our 'New Patient' blog series in the same vein, but this time, we'll give a brief (but in-depth) overview of how medical cannabis is taken and why sublingual administration is the most commonly prescribed method.
Welcome back to our 'New Patient' blog series, where we cover all the frequently asked questions, along with treatment tips and product options for new patients interested in UK medical cannabis.
Tomorrow is World Hospice and Palliative Care Day, which falls on the second Saturday of October each year and marks a time to reflect on the importance of compassionate and effective care for those facing life-limiting and terminal illnesses.
Welcome back to our 'New Patient' series, where we answer all the more frequently asked questions that prospective (and newly signed up) Releaf patients often have. In today's write-up, we explain what happens directly after you have your initial consultation with one of the specialist doctors that make up our world-class clinical team.
With a large proportion of Releaf patients choosing the Omura Vaporiser to "heat, not burn" their prescribed medical cannabis flower options, we thought it was about time to quickly discuss how to use the Flowerstick Home Fill System.
Right now, here in the UK, the stats surrounding the rates of cancer are pretty alarming - Did you know that one in two UK residents will develop some form of cancer during their lifetime?
Even though medical cannabis has been a full legal treatment option here in the UK since 1 November 2018, there is still a level of stigma surrounding it. It is anything but a surprise that some patients are worried about how their decision to pursue a medical cannabis prescription may affect their relationship with their general practitioner (GP).
Starting any new treatment option can be slightly daunting, but this is especially true when it comes to medical cannabis. Thanks to the more than century-long campaign of cannabis prohibition and stigmatisation, there is still an undercurrent of misinformation and misunderstanding around this fascinating plant and its potential therapeutic benefits - even though it has been a legal treatment option here in the UK for almost six years.
Starting your medical cannabis journey with Releaf ensures that you have access to some of the best medical cannabis specialists, treatment options, and patient care/support in the UK, but that doesn't mean you won't still have a few questions.
The UK medical cannabis sector is one of the safest and most highly regulated in the world. This is thanks to the strict procedures and guidelines put in place by regulatory bodies such as the Medicines and Healthcare product Regulatory Agency (MHRA), the Quality Care Commission (CQC), and NICE (National Institute for Health and Care Excellence). These organisations ensure that the medical cannabis products available to UK patients are safe, effective, and high quality.
Medical cannabis treatment and finding the perfect combination of cultivar (or oil) and dosage sizing is, at least in some respect, an individualised process. Some patients find the level of symptom management they are hoping for straight away, but for others, it can take a little bit of experimentation to find the balance that works best for them.
Medical cannabis has recently hit the big time here in the UK. Although it's been legal for just over six years (since November 2018), the general public's understanding of this has been surprisingly lacking. That is, until now.
Storing most medications correctly is essential to not only the shelf life but also the overall efficacy. This is (debatably) even more important when it comes to dried medical cannabis flower, as it is an organic product, unlike most conventional pharmaceuticals.
To mark our 16th instalment, we thought we would run through all the previously answered questions in one easy-to-read list. Think of this blog as your ‘cheat sheet’ to the most pressing questions new medical cannabis patients usually have.
Decisions surrounding palliative care are something that almost all of us will face at some point in our lives, whether for ourselves or for someone we care deeply about. But before that time comes, it's a subject that is often avoided or at least slightly misunderstood.
"Since starting my treatment plan with Releaf, I’m genuinely shocked at how well it has worked."Chloe Durrington, Releaf patient
